SCHEMBL2736863

SCHEMBL2736863

Nc1cccc2oncc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.44
ALDH1A1 P00352 5/20 0.44
HPGD P15428 4/20 0.44
HSD17B10 Q99714 3/20 0.44
TSHR P16473 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
BRD4 O60885 1/20 0.41
LMNA P02545 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KEAP1 Q14145 1/20 0.38
NR4A2 P43354 1/20 0.35
TDO2 P48775 7/20 0.35
KDM4E B2RXH2 3/20 0.34
KMT2A Q03164 3/20 0.34
POLB P06746 2/20 0.34
GAA P10253 2/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2005193 0.76 BRD4 (0.42) CYP3A4ALDH1A1HPGDHSD17B10TSHR
SCHEMBL20871562 0.74 BRD4 (0.41) BRD4
SCHEMBL2005190 0.74 BRD4 (0.41) BRD4LMNASMN1; SMN2HIF1A
SCHEMBL2003887 0.71 ALDH1A1 (0.44) ALDH1A1HPGDHSD17B10TSHRBRD4
SCHEMBL24399382 0.69 BRD4 (0.42) ALDH1A1BRD4LMNAKDM4EKMT2A
SCHEMBL21026104 0.69 BRD4 (0.42) ALDH1A1TSHRTDP1BRD4NPSR1
SCHEMBL30712749 0.69 BRD4 (0.60) CYP3A4ALDH1A1HPGDHSD17B10TSHR
SCHEMBL21807206 0.69 LMNA (0.41) TSHRBRD4LMNACYP2C19TDO2
SCHEMBL29956060 0.69 BRD4 (0.42) BRD4SMN1; SMN2HIF1A
SCHEMBL9910068 0.69 BRD4 (0.42) CYP3A4HPGDTSHRBRD4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2578583-A1 Fused heterocyclic derivatives and methods of use Amgen Inc. (US) 2013-04-10 EP disclosed
EP-2310389-B1 HETEROCYCLES AS PROTEIN KINASE INHIBITORS AMGEN INC (US) 2012-01-04 EP disclosed
WO-2009143477-A1 HETEROCYCLES AS PROTEIN KINASE INHIBITORS AMGEN INC. (US) 2009-11-26 WO disclosed
WO-2009091374-A2 FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2009-07-23 WO disclosed